Search for: "Eli Lilly " Results 301 - 320 of 2,147
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jun 2009, 9:22 am
For more information, including a listing of studies of note for ALIMTA and the times they will be presented, see Eli Lilly's press release [read post]
4 Jan 2013, 2:53 pm
They contend that Eli Lilly failed to provide any warnings that taking DES could injure the babies. [read post]
1 Oct 2007, 12:20 pm
Updating this Dec. 27, 2006 ILB entry, headed "Lilly wins major Zyprexa patent case," (and including a link to the United States Court of Appeals for the Federal Circuit 23-page opinion in the case of Eli Lilly v. [read post]
19 Dec 2006, 11:37 am
The drug has become Eli Lilly's best selling product, with more than $4.2 billion in sales last year. [read post]
9 Feb 2011, 7:36 am
Patent numbers 5,859,006 and 6,140,329, were filed by Icos Corporation, which was acquired by Indiana-based Eli Lilly in 2007. [read post]
12 Jul 2017, 2:30 am by Matrix Legal Support Service
This appeal considered whether a new pemetrexed based cancer treatment produced by Actavis UK Ltd & others infringes Eli Lilly & Co’s patent and its foreign designations either indirectly under the Patents Act 1977, s 60(2) (matter for appeal) or directly under a proper interpretation of the Europe Patent Convention 2000, art 69 (matter for cross-appeal). [read post]
25 Jul 2017, 5:34 am
UNCT/14/2 Eli Lilly & Co. v Government of Canada, (16 March 2017) ICSID At 10:00 on 17 Aug 2017 I shall give a talk to the IP Summer School at Cambridge entitled Bilateral Investment Treaties & Exporters' Rights Post-Brexit. [read post]
2 Nov 2009, 11:04 pm
Amylin Pharmaceuticals Inc. and Eli Lilly & Co. said safety warnings were strengthened for their diabetes drug Byetta relating to the risks of pancreatitis and the medicine's use by patients with severe kidney disease. [read post]
19 Aug 2010, 9:55 pm by Patent Docs
By James DeGiulio -- Lilly's Patent for Strattera Found Invalid, Lilly Appeals to Federal Circuit Teva Pharmaceuticals USA, Mylan Pharmaceuticals, and Apotex successfully argued that Eli Lilly's patent for the ADHD drug Strattera (U.S. [read post]
Joining the majority of European courts, the Paris Court of Justice ruled that Eli Lilly’s patent, which relates to the combined administration of pemetrexed disodium and vitamin B12, was infringed by the marketing of Fresenius’ pemetrexed diacid. [read post]
13 Nov 2011, 1:53 pm by Tom Huddleston Jr.
The Skadden M&A partner led the firm's team advising Amylin Pharmaceuticals on an agreement that ends litigation with Eli Lilly and also dissolves an Amylin-Lilly alliance aimed at developing and selling diabetes drugs--with Amylin in line to acquire full global rights to those drugs over the next two years. [read post]
2 Dec 2009, 6:19 am
"Calling Mississippi Attorney General Jim Hood's lawsuit against Eli Lilly & Co. a 'slash-and-burn style of litigation,' the federal judge overseeing Zyprexa lawsuits has granted Lilly summary judgment. [read post]
5 Feb 2008, 7:16 pm
Here's an excerpt: A Food and Drug Administration official said that a long-acting, injectable form of Eli Lilly & Co.'s top-selling... [read post]
24 Jul 2014, 12:54 pm
Indianapolis, Indiana - In conjunction with co-counsel, an Indiana patent attorney for Eli Lilly of Indianapolis, Indiana prevailed in the Southern District of Indiana on claims of patent infringement. [read post]
9 Apr 2007, 12:11 pm
The Republican Senator from Iowa wants Eli Lilly to produce documents that may suggest Lilly didn't play fair in touting Zyprexa, often used to treat schizophrenia and bipolar disorder.Senator Grassley wants Lilly to provide "e-mails, letters, reports" and other internal documents relating to Zyprexa. [read post]